相关实验视频

Updated: Jun 24, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

如何将新药纳入用于胆管癌的精密药物中?

Yifan Li¹, Juying Kang², Xiaojuan Zhang³

¹Department of Hepatobiliary, Pancreatic and Gastrointestinal Surgery, Shanxi Province Carcinoma Hospital, Shanxi Hospital Affiliated to Carcinoma Hospital, Chinese Academy of Medical Sciences, Carcinoma Hospital Affiliated to Shanxi Medical University Taiyuan 030013, Shanxi, PR China.

American journal of cancer research

|June 11, 2024

概括

精准医学为胆管癌治疗提供了新的希望. 向疗法和免疫疗法通过向特定的基因突变和增强免疫反应以获得更好的患者结果,显示出有希望.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
免疫学免疫学免疫学

背景情况:

胆管癌是一种罕见的,侵略性的肝癌,治疗选择有限.
精准医学为更有效的胆管癌治疗提供了一个有希望的途径.

研究的目的:

探索精准医学在治疗胆管癌中的作用.
突出针对性治疗和免疫治疗的潜力.

主要方法:

使用针对特定基因突变的向药物 (例如,IDH1,IDH2).
使用免疫检查点抑制剂 (例如布罗利祖马布,尼沃卢马布).
通过下一代测序进行分子分析.

主要成果:

向治疗显示对具有特定突变的胆管癌具有有效性.
免疫疗法显示出有希望的结果,特别是在高瘤透淋巴细胞或微卫星不稳定的患者中.
分子造型识别为个性化治疗计划确定可操作的目标.

结论:

精确医学,包括向疗法和免疫疗法,正在推进胆管癌治疗.
基于分子分析的个性化治疗策略对于改善患者的治疗结果至关重要.
对分子变化的进一步研究可能会发现更多的治疗点.

关键词:

胆性瘤是一种胆性瘤.精准医学是一门精准的医学.有针对性的治疗.

更多相关视频

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...